FDA Announces 20 Dangerous Drugs You Should NOT Be On

drugs, pharmaceuticals, medicine, dangerous drugs, FDA, big pharma, pharmaceutical companies, pharmaceutical industry, GDP, gross domestic product, power, influenceA 2007 federal law requires the FDA to disclose all its investigations into reports of possibly drug-related adverse events. The first of this series of quarterly reports has been released. It includes adverse events reported between January 1 and March 31, 2008.

Here’s the list of drugs and the adverse events that have been reported:

  1. Arginine Hydrochloride Injection (R-Gene 10) — Pediatric overdose due to labeling and packaging confusion
  2. Desflurane (Suprane) — Cardiac arrest
  3. Duloxetine (Cymbalta) — Urinary retention
  4. Etravirine (Intelence) — Hemarthrosis (blood in a joint)
  5. Fluorouracil Cream (Carac) and Ketoconazole Cream (Kuric) — Adverse events due to name confusion
  6. Heparin — Anaphylactic-type (life-threatening allergic) reactions
  7. Icodextrin (Extraneal) — Hypoglycemia (low blood sugar)
  8. Insulin U-500 (Humulin R) — Dosing confusion
  9. Ivermectin (Stromectol) and Warfarin — Drug interaction
  10. Lapatinib (Tykerb) — Hepatotoxicity (liver toxicity)
  11. Lenalidomide (Revlimid)Stevens-Johnson syndrome (a deadly drug reaction)
  12. Natalizumab (Tysabri) — Skin melanomas (deadly skin cancer)
  13. Nitroglycerin (Nitrostat) — Overdose due to labeling confusion
  14. Octreotide Acetate Depot (Sandostatin LAR) — Ileus (bowels not moving)
  15. Oxycodone Hydrochloride Controlled-Release (OxyContin) — Drug misuse, abuse, and overdose
  16. Perflutren Lipid Microsphere (Definity) — Cardiopulmonary reactions (lung/heart problems)
  17. Phenytoin Injection (Dilantin) — Purple glove syndrome (discoloration, pain, and swelling of the hand that may lead to amputation)
  18. Quetiapine (Seroquel) — Overdose due to sample pack labeling confusion
  19. Tebivudine (Tyzeka) — Peripheral neuropathy (tingling or numbness in the extremities)
  20. Tumor Necrosis Factor (TNF) Blockers — Cancers in children and young adults
Reblog this post [with Zemanta]

Leave a Reply

Your email address will not be published. Required fields are marked *